Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Influenza

Free Subscription 20.10.2025 3 Antiviral Res 1 BMC Pediatr 23 J Infect Dis 3 PLoS Comput Biol 1 PLoS Med 13 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. PATEL MC, Nguyen HT, Mishin VP, Pascua PNQ, et al
   Antiviral susceptibility monitoring: testing algorithm, methods, and findings for influenza season, 2023-2024.
   Antiviral Res. 2025 Oct 11:106299. doi: 10.1016/j.antiviral.2025.106299.
   PubMed         Abstract available
   
   
2. ZHU C, Wang Z, Pan Z, Mai X, et al
   DMBT1 promotes SARS-CoV-2 infection and its SRCR-derived peptide inhibits SARS-CoV-2 infection.
   Antiviral Res. 2025 Sep 3:106269. doi: 10.1016/j.antiviral.2025.106269.
   PubMed         Abstract available
   
   
3. TASHIMA R, Kuroda T, Nobori H, Miyagawa S, et al
   Ensitrelvir suppresses prolonged olfactory abnormalities derived from SARS-CoV-2 infection in hamsters.
   Antiviral Res. 2025 Sep 2:106270. doi: 10.1016/j.antiviral.2025.106270.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

4. WU LE, Wei JY, Lin ZH, Li HC, et al
   Clinical characteristics of children with idiopathic nephrotic syndrome infected with SARS-CoV-2: a single-center retrospective cohort study.
   BMC Pediatr. 2025;25:803.
   PubMed         Abstract available
   
   

   
   J Infect Dis

5. HENAUT M, Carbonneau J, Levade I, Boivin G, et al
   Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing.
   J Infect Dis. 2025;232:e656-e660.
   PubMed         Abstract available
   
   
6. KITTIKRAISAK W, Mohanty S, Klungthong C, Macareo L, et al
   Antenatal Respiratory Syncytial Virus and Human Metapneumovirus Illness Rates Among Pregnant Women in Thailand and the Association Between Antenatal Respiratory Syncytial Virus and Perinatal Outcomes: A Prospective Cohort Study.
   J Infect Dis. 2025;232:e651-e655.
   PubMed         Abstract available
   
   
7. ATMAR RL, Lyke KE, Posavad CM, Deming ME, et al
   Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
   J Infect Dis. 2025 Apr 29:jiaf176. doi: 10.1093.
   PubMed         Abstract available
   
   
8. JIANG D, Hurst JH, Mohamed G, Kelly MS, et al
   Decreased Microbiota-Driven Tyrosine Metabolism Is Associated With Symptomatic COVID-19 in Children.
   J Infect Dis. 2025;232:796-805.
   PubMed         Abstract available
   
   
9. SAMANDARI T, Achola M, Hutter JN, Mboya G, et al
   Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults.
   J Infect Dis. 2025 Aug 2:jiaf398. doi: 10.1093.
   PubMed         Abstract available
   
   
10. BUI VL, Ragonnet R, Hughes AE, Shipman DS, et al
    Impact of Case Detection and Covid-19-Related Disruptions on Tuberculosis In Vietnam: A Modelling Analysis.
    J Infect Dis. 2025 Aug 7:jiaf406. doi: 10.1093.
    PubMed         Abstract available
    
    
11. WAITE AAC, Peto L, Gordon AC, Horby P, et al
    Platform Trials to Assess Therapeutics in Patients Hospitalized With Influenza.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
12. BRIGHT RA
    Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic Framework.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
13. SHINDO N, Huvos A, Nguyen T
    Evolution of WHO Influenza Antiviral Stockpile: Rapid Access and Use in Low- and Middle-Income Countries for Pandemic Preparedness and Response.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
14. HAYDEN FG, Whitley RJ
    Introduction and Update: Advances in Influenza Therapeutics.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
15. LEE K, Pavia AT, Englund JA
    Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir?
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
16. TAKASHITA E, Wolfe CR, Jones JC
    Laboratory Methods for Monitoring Influenza Antiviral Resistance.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
17. DAMHORST GL, Lam WA
    Point-of-care and Home Use Influenza Diagnostics for Advancing Therapeutic and Public Health Strategies.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
18. ZAMBON M, Myles P, Sugaya N
    Use of Influenza Antivirals in Pandemic Response.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
19. BEIGEL JH, Oldach D
    Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
20. HASTINGS LE, Acosta EP, Kimberlin DW
    Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
21. KARAKONSTANTIS S, Lytras T, Keske S, Tsiodras S, et al
    The Care Continuum of Patients With Influenza in the Post-COVID-19 Era: A Position Paper.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
22. HELDMAN MR, Boeckh MJ, Ison MG
    Influenza Antivirals for Prevention and Treatment in Immunocompromised People.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
23. COWLING BJ, Lin Y, Ikematsu H
    Use of Influenza Antivirals to Prevent Transmission.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
24. PASCO R, Hayden FG, Meyers LA
    Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
25. LI J, Jin Y, Wang Y, Shang L, et al
    New Developments in Influenza Polymerase Inhibitors.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
26. UYEKI TM, Belser JA
    Antivirals for Novel Influenza A Virus Infections.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
27. HUI DSC, Chan KKP
    Host Immunomodulatory Interventions in Severe Influenza.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

28. JOUBBI S, Micheli A, Milazzo P, Ciano G, et al
    Enhancing antibody-antigen interaction prediction with atomic flexibility.
    PLoS Comput Biol. 2025;21:e1013576.
    PubMed         Abstract available
    
    
29. ERANTI P, Hegde M, Al Sium SM, Parra RG, et al
    Impact of the COVID-19 pandemic on computational biology early career researchers: A global retrospective study.
    PLoS Comput Biol. 2025;21:e1013554.
    PubMed         Abstract available
    
    
30. TORRAS-PEREZ M, Yoon IHR, Weeratunga P, Ho LP, et al
    Topology across scales on heterogeneous cell data.
    PLoS Comput Biol. 2025;21:e1013460.
    PubMed         Abstract available
    
    

    
    PLoS Med

31. KAWAMOTO A, Hashida M, Ishida K, Furihata K, et al
    Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine: A phase 3, randomized, active-controlled study.
    PLoS Med. 2025;22:e1004499.
    PubMed         Abstract available
    
    

    
    PLoS One

32. RISNER M, Hu L, Stamoulis C
    Pre-pandemic mental health and brain characteristics predict adolescent stress and emotions during the COVID-19 pandemic.
    PLoS One. 2025;20:e0334028.
    PubMed         Abstract available
    
    
33. HADAYA J, Ebrahimian S, Cho NY, Kim S, et al
    Trends and outcomes of cardiac arrest and extracorporeal membrane oxygenation during the COVID-19 pandemic in the United States.
    PLoS One. 2025;20:e0334896.
    PubMed         Abstract available
    
    
34. MAGBOR P, Wang WZ, Gugan G, Olabode AS, et al
    Spatiotemporal structure of SARS-CoV-2 mutational frequencies in wastewater samples from Ontario.
    PLoS One. 2025;20:e0333945.
    PubMed         Abstract available
    
    
35. DUBUIS ME, Racine E, Vyskocil JM, Turgeon N, et al
    Correction: Ozone inactivation of airborne influenza and lack of resistance of respiratory syncytial virus to aerosolization and sampling processes.
    PLoS One. 2025;20:e0334842.
    PubMed         Abstract available
    
    
36. WAGELAAR EM, Hogeveen LS, Jonkman NH, Bakker A, et al
    Healthcare employees' perspectives on organizational communication about preventive mental health interventions: A focus group study.
    PLoS One. 2025;20:e0334716.
    PubMed         Abstract available
    
    
37. ELLEGAARD KM, Gunalan V, Sieber R, Baig SJ, et al
    SARS-CoV-2 sequencing artifacts associated with targeted PCR enrichment and read mapping.
    PLoS One. 2025;20:e0334009.
    PubMed         Abstract available
    
    
38. SHAKEEL I, Rashid HB, Ain QU, Inayat A, et al
    Prevalence and risk factors of Influenza Avian Virus in backyard pigeons, ducks, and chickens in Toba Tek Singh District, Pakistan.
    PLoS One. 2025;20:e0314186.
    PubMed         Abstract available
    
    
39. NAGRA G, Ezeugwu VE, Bostick GP, Branton E, et al
    Return-to-work for people living with long COVID: A scoping review of interventions and recommendations.
    PLoS One. 2025;20:e0321891.
    PubMed         Abstract available
    
    
40. MEJIA GOMEZ LA, Menendez D, Umscheid V, Gelman SA, et al
    Who gets sicker and why? Parents' perceptions of COVID-19 disparities and how they would explain them to their children.
    PLoS One. 2025;20:e0332140.
    PubMed         Abstract available
    
    
41. HOSSEN MT, Alam MSB, Islam MS, Montomoli E, et al
    Impact of the COVID-19 pandemic on the routine immunization system in Bangladesh.
    PLoS One. 2025;20:e0334503.
    PubMed         Abstract available
    
    
42. WENG PY, Li D, Liao ML, Chiang YC, et al
    Aging in rural communities: Engagement in indoor leisure activities and older adult health.
    PLoS One. 2025;20:e0334111.
    PubMed         Abstract available
    
    
43. GAO F, Wang D, Zuo L, Sun J, et al
    Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases.
    PLoS One. 2025;20:e0327297.
    PubMed         Abstract available
    
    
44. CHICOINE N, Griffin J
    The unreliability of estimated release dates in hospital drug shortage management: A case study of hospital pharmacy operations during the COVID-19 pandemic.
    PLoS One. 2025;20:e0328747.
    PubMed         Abstract available
    
    

    
    Vaccine

45. PIRES C
    Influenza vaccine hesitancy in the elderly: Where do we stand?
    Vaccine. 2025;66:127831.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.